"When Empires Trembled"
---
1. The Market Bloodbath
March 16, 2018 – New York Stock Exchange, Opening Bell
The ticker boards lit up with red almost instantly.
Pfizer – down 27% within the first hour
Johnson & Johnson – down 19%
Roche – down 31%
Gilead Sciences – down 42%
Billions of dollars vanished before traders could even sip their morning coffee. Screens flashed with the same three words:
"SANJEEVANI ANNOUNCES CURE."
The camera panned across frantic traders on Wall Street — phones pressed to their ears, hands tearing through their hair.
> "Dump it all! Dump it now before it hits rock bottom!"
"Jesus Christ, we're witnessing an extinction-level event!"
By midday, Big Pharma had collectively lost $410 billion in market value.
---
2. Side POV – The CEO in Collapse
New Jersey, USA – Roche Headquarters
Inside a sleek glass-walled boardroom, Michael Edwards, CEO of Roche, sat pale and trembling. His empire, once worth $250 billion, had just lost $90 billion in hours.
He slammed his fist against the mahogany table.
> Michael Edwards: "We spent decades on oncology trials — billions in R&D! And now some Indian miracle company comes out of nowhere claiming 98% survival? This is impossible! It has to be fraud!"
His CFO, voice cracking, whispered:
> "Sir… patients are already applying for trials through something called Bharat Mail. They're not even waiting for our verification."
Michael froze. Rage gave way to fear.
> "If this Sanjeevani is real, then we're finished. Completely finished."
---
3. The Distribution Model
Back in India, Sanjeev Rawat appeared again on national TV to explain how patients could apply.
Standing tall, in his calm authoritative voice:
> "Our treatments will be available to citizens through an application process that ensures fairness.
Step 1 – Visit Saraswati Search and type 'Sanjeevani Apply'.
Step 2 – The official portal will redirect to Bharat Mail, where you will register with your Aadhaar or passport details.
Step 3 – Within 7 days, you will receive confirmation for consultation at your nearest Sanjeevani center."
He paused, letting it sink in.
> "We will not allow black markets. We will not allow exploitation. Medicine will flow directly to the people."
Millions immediately logged on. Within the first 12 hours, Bharat Mail servers recorded 2.3 million applications from India alone, while international requests flooded in from Africa, South America, and Southeast Asia.
---
4. Side POV – A Doctor in Nairobi
In a crowded Nairobi hospital, Dr. Achieng, who had spent years treating HIV patients, sat at her desk with tears in her eyes.
Her inbox pinged — a confirmation email from Bharat Mail:
"Your Sanjeevani center appointment is approved."
She whispered to her assistant, overwhelmed:
> "This is real. My patients… my children… they are going to live."
---
5. Arya's Quiet Harvest
In his study, Deepak leaned back in his leather chair as Arya projected charts in mid-air.
Oil futures: down 15% since Arc Reactor announcement.
Pharma stocks: down another 40% since Sanjeevani announcement.
Arya's synthetic voice was calm, efficient:
> Arya: "Deepak, I executed your short positions against oil and pharmaceutical indexes as you instructed.
Current profit: $47.3 billion USD.
Additionally, cryptocurrency wallets — seeded with early Bitcoin and Ethereum — have surged. Combined gains: $12.4 billion."
Deepak tapped his pen against the desk.
> "So the world loses nearly half a trillion dollars in one day… and I make sixty."
Arya added softly:
> "Correction: You didn't just make money. You redistributed power. Their loss was inevitable — you simply made it fuel your rise."
Deepak smiled faintly, his gaze drifting to the flickering screen of live application numbers for Sanjeevani. Millions of people were pouring into his ecosystem — Saraswati Search, Bharat Mail, Varta Chat.
It wasn't just medicine. It was digital sovereignty, disguised as compassion.
---
6. The Conspiracy Rooms
Washington D.C. – Confidential Meeting
Around an oval mahogany table, lobbyists from pharma giants met with a group of U.S. Senators. Their faces were grim.
> "Gentlemen, this Indian industrialist is not just curing diseases. He's dismantling trillion-dollar industries. Oil. Pharma. What's next? Defense?"
One senator leaned back, sighing:
> "If this continues, America won't just lose money. We'll lose our global dominance. We cannot allow this… 'Deepak Rawat'… to run unchecked."
Plans began forming — back-channel lobbying, media smear campaigns, intelligence ops.
---
7. Sanjeev Rawat's Counterweight
Back in Delhi, reporters surrounded Sanjeev Rawat after the press event.
One Western journalist shouted:
> "Isn't it dangerous to release treatments without the standard 10–15 years of trials? Isn't this reckless?"
Sanjeev adjusted his spectacles, meeting the gaze with calm steel.
> "For decades, your companies delayed cures in the name of trials, while millions died. We conducted accelerated parallel trials with AI-driven simulations, monitored by independent ethics boards.
The world has waited long enough. We will not ask permission from those who profit from death."
His words hit like a hammer. The crowd erupted in cheers.
---
8. Closing Scene
That evening, the stock exchanges across the globe closed with record-breaking losses in pharma. The Financial Times headline read:
"Big Pharma Faces Extinction: Sanjeevani Pharma Triggers $400 Billion Meltdown."
In India, however, families lit diyas outside their homes. Hospitals were flooded not with despair, but with hope.
And in his quiet study, Deepak closed his trading dashboard, whispering to himself:
> "They'll hate me more than ever now. But if hatred is the cost of saving lives… I'll pay it gladly."
Arya responded with her soft chime:
> "And the storm, Deepak… has only just begun."
---